Tokuhisa, Teruaki http://orcid.org/0000-0002-0681-246X
Watanabe, Tomoyuki
Watanabe, Akira
Nakano, Tadashi
Article History
Received: 31 January 2021
Accepted: 21 October 2021
First Online: 22 January 2022
Declarations
:
: Financial interests: Author T. Nakano has received Grant from CREWT Medical Systems, Kyowa Medical, Kuribara Medical Instruments, Kowa, Tomey, Otsuka Pharmaceutical, Senju Pharmaceutical, MSD, Pfizer, Alcon Japan, Santen Pharmaceutical, NIDEK, AMO Japan Bayer, and IOL MEDICAL. Author T. Nakano has also received Personal Fees from Kowa, Otsuka Pharmaceutical, Senju Pharmaceutical, Santen Pharmaceutical, Nitto Medical, and Nikon.
: This study was conducted with approval from the institutional review board and in accordance with the ethical standards of the Helsinki Declaration of 1975, as revised in 2000 and 2008.The study protocol was approved by the Institutional Review Board of the Jikei University School of Medicine (approval no.:31–421[10003]), and all clinical procedures were conducted according to the principles of the Declaration of Helsinki.
: The study protocol was disclosed, and patients were given the opportunity to refuse participation in the study.
: The study protocol was disclosed, and patients were given the opportunity to refuse participation in the study.